Review of ongoing clinical trials in non-small-cell lung cancer: A status report for 2012 from the ClinicalTrials.gov web site

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Ongoing Clinical Trials 100%
• Status Report 100%
• United States 50%
• Lung Cancer 33%
• Patient Selection 33%
• Clinical Cancer Research 33%
• Cancer Tumor 16%
• Major Change 16%
• Targeted Therapy 16%
• China 16%
• Tumor Histology 16%
• Targeted Agents 16%
• Phase II Trial 16%
• Clinical Research 16%
• Rapidly Evolving 16%
• Molecular Targeted Agents 16%
• Biomarker Testing 16%
• Pediatric Research 16%
• Open Study 16%
• Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI) 16%
• Accruals 16%
• Biomarker Analysis 16%
• Drop-down 16%
• Advanced Search 16%
• Industry-sponsored Trials 16%
• Search Function 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Non Small Cell Lung Cancer 100%
• Biological Marker 50%
• Clinical Research 50%
• Lung Cancer 33%
• Neoplasm 16%
• Epidermal Growth Factor Receptor Kinase Inhibitor 16%

Biochemistry, Genetics and Molecular Biology

• Clinical Trial 100%
• Clinical Research 100%
• Epidermal Growth Factor Receptor 33%
• Receptor Tyrosine Kinase Inhibitors 33%